MedTrace Logo

Exercise Intervention for LGBT Cancer Survivors

NCT02459769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-11-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test preliminary efficacy, as well as acceptability and feasibility, of a dyadic exercise intervention, the current study will randomize LGBT cancer survivors and their non-professional caregivers as dyads to either an individual or a dyadic Exercise for Cancer Patients (EXCAP) intervention. The primary outcome assessed will be psychological distress. Analyses will involve pre-post comparisons of outcomes across the study arms, testing the hypothesis that a 6 week, daily, dyadic exercise intervention will result in greater improvements in psychological distress than an individual intervention.

Conditions

  • Neoplasms

Interventions

BEHAVIORAL

Exercise for Cancer Patients

a standardized, daily, 6 week, home-based, progressive exercise program

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Charles Kamen, PhD, MPH · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-15
Primary Completion
2021-02-22
Completion
2021-02-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02459769 on ClinicalTrials.gov